Dempze Nancy E Vertex Pharmaceuticals Inc Transaction History
Dempze Nancy E
- $158 Million
- Q2 2025
A detailed history of Dempze Nancy E transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dempze Nancy E holds 7,180 shares of VRTX stock, worth $3.37 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
7,180
Previous 7,063
1.66%
Holding current value
$3.37 Million
Previous $3.42 Million
6.66%
% of portfolio
2.02%
Previous 2.26%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$13.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.82 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.53 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...